CAS: 1395493-35-2
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | 1-Phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine REF: IN-DA00HVNICAS: 1395493-35-2 | 95% | Nachfragen | Mi 02 Okt 24 |
 | 1-Phenyl-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridine REF: 3D-VFC49335CAS: 1395493-35-2 | Min. 95% | Nachfragen | Mi 13 Nov 24 |
![1-Phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine](https://static.cymitquimica.com/products/IN/thumb/DA00HVNI.jpg)
1-Phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine
CAS:1395493-35-2
Formel:
C12H13N3
Reinheit:
95%
Molekulargewicht:
199.2517
Ref: IN-DA00HVNI
| 1g | Nachfragen | ||
| 100mg | 158,00 € | ||
| 250mg | 265,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Mittwoch 2. Oktober 2024
![1-Phenyl-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridine](https://static.cymitquimica.com/products/3D/thumb/VFC49335.jpg)
1-Phenyl-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridine
CAS:1395493-35-2
Apixaban is an oral, direct factor Xa inhibitor. Apixaban binds reversibly to the active site …
Formel:
C12H13N3
Reinheit:
Min. 95%
Molekulargewicht:
199.25 g/mol
Ref: 3D-VFC49335
| 1g | 715,00 € | ||
| 100mg | 181,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Mittwoch 13. November 2024
